Recent Updates
Recently added Catalysts
ELUT Positive Sentiment Score: 75/100

Elutia to Present at Planet MicroCap Showcase 2026 on June 17th

Key Takeaway: Elutia Inc. will present at the Planet MicroCap Showcase 2026 on June 17-18, 2026, in Las Vegas. CEO Dr. Randy Mills and CSO Dr. Michelle Williams will discuss their innovative drug-eluting biomatrix technology aimed at reducing post-surgical infections in breast reconstruction. The event includes one-on-one meetings with investors, emphasizing Elutia's commitment to improving patient outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elutia is addressing significant challenges in post-surgical infection.
  • The company is showcasing innovative drug-eluting biomatrix technology.
  • Management's engagement with investors highlights confidence in their solutions.

Full Press Release Details

GAITHERSBURG, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer, and Dr. Michelle Williams, Chief Scientific Officer, will present and host one-on-one meetings with investors at the Planet MicroCap Showcase 2026 at the Bellagio in Las Vegas, Nevada on June 17–18, 2026.
During the presentation, management will discuss how Elutia is working to address post-surgical infection in implant-based breast reconstruction following mastectomy—one of the most significant challenges facing patients and surgeons—through its drug-eluting biomatrix technology designed to support safer, more reliable reconstructive outcomes.
The Company will highlight its focus on improving outcomes in implant-based breast reconstruction, where infection remains a leading cause of complications and revision surgeries for patients undergoing reconstruction after breast cancer treatment.
The presentation will begin at 2:00 pm Pacific Time on Wednesday, June 17, 2026, and can be accessed live here:Webcast.Watch ourcompany video on reducing infection risk and commercial adoption.Elutia will also host one-on-one meetings with investors on June 17–18, 2026. To register for the presentation or schedule a one-on-one meeting, visitPlanet MicroCap.

About Planet MicroCap

Planet MicroCap Showcase is the premier investor conference dedicated to micro-cap companies, connecting executives with institutional and retail investors through company presentations, one-on-one meetings, and networking events. The annual showcase is held in Las Vegas and draws participants from across the investment community. For more information, visitwww.planetmicrocap.com.

About Elutia

Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia's mission is humanizing medicine so patients can thrive without compromise. For more information, visitwww.Elutia.com.

Investors:

Elutia Investor Relations

Frequently Asked Questions

When will Elutia present at the Planet MicroCap Showcase?

Elutia will present on June 17, 2026, at the Planet MicroCap Showcase.

Who will represent Elutia at the showcase?

CEO Dr. Randy Mills and CSO Dr. Michelle Williams will represent Elutia.

What technology will Elutia discuss at the event?

Elutia will discuss its drug-eluting biomatrix technology for breast reconstruction.

Where is the Planet MicroCap Showcase held?

The showcase will take place at the Bellagio in Las Vegas, Nevada.

Last updated: Jun 11, 2026